InvestorsHub Logo

chumppunk

10/10/20 12:06 PM

#122490 RE: hopester #122489

hopester- Costs to aquire goods to manufacture/label, distribute/shelf life and price. All accounting fair total assests whether used or not. JC Penny has a larger Total Asset value. Invest in it then.
CHump

justdafactss

10/10/20 12:06 PM

#122491 RE: hopester #122489

Yup, that $38M "work-in-progress" was a hoot.



Some of the most ridiculous book cooking I've ever seen.

Its like Ford or GM having all the parts to manufacture a car (seats, tires, engines, transmissions, light bulbs, etc.) but counting those unassembled parts as completed vehicles loaded on semi trailers and rail cars in route to dealerships.

Grip it and Sip It

10/10/20 12:09 PM

#122492 RE: hopester #122489

I did notice that and thought it’s part of the reason Nader wants all of those vials produced before approval and a single order.

The auditors could, under GAAP, assign that a value of $0. In essence, that is the street value. Who would buy it?

The financials are juiced for the time being but in the end, that asset is what the highest bidder will pay.
I don’t believe uplist is a possibility and is <10%. Nader just stringing that along and probably keeping it alive just enough to avoid having to 8k the denial.

It will be announced after the CD12 preliminary findings are announced. He always needs the rabbit for the dogs to chase... yet the dogs never catch the rabbit but keep running around the track putting miles on but going nowhere

Grip